<DOC>
	<DOCNO>NCT01421095</DOCNO>
	<brief_summary>Young adult cancer survivor constitute serve population fertility potential particularly important . For female young adult patient , cancer treatment alkylating chemotherapy toxic finite number egg , result risk infertility premature menopause relate ovarian failure . Reproductive issue major concern young cancer survivor , one understudied . Young cancer survivor tool measure post-treatment ovarian reserve , quantity quality remain eggs4 . Accurate determination ovarian reserve fertility potential would important research tool , also directly impact clinical management . The purpose study test basal provocative ovarian reserve test predict return menses female young adult cancer survivor , compare basal provocative ovarian reserve test result female young adult cancer survivor healthy control , compare basal provocative ovarian reserve test result female young adult cancer survivor combine estrogen progesterone hormone product . Participants ask keep track period three month . If participant take birth control pill , patch , vaginal ring , ask come birth control 3 month . Participants also ask undergo ovarian reserve test blood draw pelvic ultrasound start end 3 month .</brief_summary>
	<brief_title>Ovarian Reserve Testing Female Young Adult Cancer Survivors</brief_title>
	<detailed_description>Same brief summary</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<criteria>Postmenarchal Cancer diagnosis Prior exposure gonadotoxic therapy , inclusive chemothearpy , pelvic total body irradiation , unilateral oophorectomy A minimum 1 year since completion gonoadotoxic therapy Intact uterus At least one ovary Estrogen receptor positive cancer</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Fertility</keyword>
	<keyword>adolescent</keyword>
	<keyword>young adult</keyword>
	<keyword>cancer survivor</keyword>
</DOC>